Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses. Our purpose is to turn untapped potential into global medical therapies that improve our patients' lives. Apollo Global Management, with $455 billion AUM, is the private equity sponsor of Covis Pharma.
Looking for a particular Covis Pharma employee's phone or email?
The Covis Pharma annual revenue was $15.5 million in 2026.
Raghav Chari is the Chief Innovation Officer of Covis Pharma.
118 people are employed at Covis Pharma.
Covis Pharma is based in Zug, Zug.
The NAICS codes for Covis Pharma are [32, 32541, 3254, 325].
The SIC codes for Covis Pharma are [28, 283].